Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation
- PMID: 14641014
- DOI: 10.1042/bst0311143
Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation
Abstract
PDC (pyruvate dehydrogenase complex) catalyses the oxidative decarboxylation of pyruvate, linking glycolysis to the tricarboxylic acid cycle. Regulation of PDC determines and reflects substrate preference and is critical to the 'glucose-fatty acid cycle', a concept of reciprocal regulation of lipid and glucose oxidation to maintain glucose homoeostasis developed by Philip Randle. Mammalian PDC activity is inactivated by phosphorylation by the PDKs (pyruvate dehydrogenase kinases). PDK inhibition by pyruvate facilitates PDC activation, favouring glucose oxidation and malonyl-CoA formation: the latter suppresses LCFA (long-chain fatty acid) oxidation. PDK activation by the high mitochondrial acetyl-CoA/CoA and NADH/NAD(+) concentration ratios that reflect high rates of LCFA oxidation causes blockade of glucose oxidation. Complementing glucose homoeostasis in health, fuel allostasis, i.e. adaptation to maintain homoeostasis, is an essential component of the response to chronic changes in glycaemia and lipidaemia in insulin resistance. We develop the concept that the PDKs act as tissue homoeostats and suggest that long-term modulation of expression of individual PDKs, particularly PDK4, is an essential component of allostasis to maintain homoeostasis. We also describe the intracellular signals that govern the expression of the various PDK isoforms, including the roles of the peroxisome proliferator-activated receptors and lipids, as effectors within the context of allostasis.
Similar articles
-
Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.Curr Drug _targets Immune Endocr Metabol Disord. 2002 Jul;2(2):151-65. Curr Drug _targets Immune Endocr Metabol Disord. 2002. PMID: 12476789 Review.
-
Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs.Am J Physiol Endocrinol Metab. 2003 May;284(5):E855-62. doi: 10.1152/ajpendo.00526.2002. Am J Physiol Endocrinol Metab. 2003. PMID: 12676647 Review.
-
Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding.Arch Biochem Biophys. 2001 Nov 15;395(2):246-52. doi: 10.1006/abbi.2001.2586. Arch Biochem Biophys. 2001. PMID: 11697863
-
Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice.Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H270-6. doi: 10.1152/ajpheart.00852.2002. Epub 2003 Mar 27. Am J Physiol Heart Circ Physiol. 2003. PMID: 12663261
-
Therapeutic _targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx071. J Natl Cancer Inst. 2017. PMID: 29059435 Review.
Cited by
-
A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis.EMBO Mol Med. 2015 May;7(5):526-46. doi: 10.15252/emmm.201404433. EMBO Mol Med. 2015. PMID: 25820275 Free PMC article.
-
Regulation of pyruvate dehydrogenase complex related to lactate switch in CHO cells.Eng Life Sci. 2020 Sep 28;21(3-4):100-114. doi: 10.1002/elsc.202000037. eCollection 2021 Mar. Eng Life Sci. 2020. PMID: 33716610 Free PMC article.
-
Effect of exercise training on skeletal muscle protein expression in relation to insulin sensitivity: Per-protocol analysis of a randomized controlled trial (GO-ACTIWE).Physiol Rep. 2021 May;9(10):e14850. doi: 10.14814/phy2.14850. Physiol Rep. 2021. PMID: 34042297 Free PMC article. Clinical Trial.
-
Fasting induces ketoacidosis and hypothermia in PDHK2/PDHK4-double-knockout mice.Biochem J. 2012 May 1;443(3):829-39. doi: 10.1042/BJ20112197. Biochem J. 2012. PMID: 22360721 Free PMC article.
-
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic _target.Int J Oncol. 2013 Jan;42(1):44-54. doi: 10.3892/ijo.2012.1687. Epub 2012 Nov 6. Int J Oncol. 2013. PMID: 23135628 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources